search
Back to results

Effect of Nigella Sativa Seed Extract on the Blood Pressure of Elderly With Hypertension

Primary Purpose

Hypertension

Status
Unknown status
Phase
Phase 3
Locations
Indonesia
Study Type
Interventional
Intervention
Nigella sativa
Sponsored by
Indonesia University
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hypertension focused on measuring Nigella sativa seed extract, hypertension, elderly

Eligibility Criteria

60 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Men and women more than 60 years old
  • Systolic Blood Pressure 140 mm Hg AND OR diastolic blood pressure 90 mmHg
  • Available during study duration (4 weeks)

Exclusion Criteria:

  • Renal failure
  • Hepatic failure
  • Dementia
  • Orthostatic hypotension
  • Malignant hypertension

Sites / Locations

  • Cipto Mangunkusumo National HospitalRecruiting

Outcomes

Primary Outcome Measures

systolic blood pressure
We aim to measure the difference in systolic blood pressure after 4 weeks administration of 300 mg Nigella sativa seed extract in elderly with hypertension

Secondary Outcome Measures

diastolic blood pressure
We measure the difference of diastolic blood pressure after 4 weeks administration of 300 mg Nigella sativa seed extract in elderly with hypertension

Full Information

First Posted
July 12, 2011
Last Updated
July 12, 2011
Sponsor
Indonesia University
search

1. Study Identification

Unique Protocol Identification Number
NCT01393054
Brief Title
Effect of Nigella Sativa Seed Extract on the Blood Pressure of Elderly With Hypertension
Official Title
Effect of Nigella Sativa Seed Extract on the Blood Pressure of Elderly With Hypertension
Study Type
Interventional

2. Study Status

Record Verification Date
July 2011
Overall Recruitment Status
Unknown status
Study Start Date
July 2011 (undefined)
Primary Completion Date
October 2011 (Anticipated)
Study Completion Date
December 2011 (Anticipated)

3. Sponsor/Collaborators

Name of the Sponsor
Indonesia University

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Despite of the development of new anti hypertensive agents, hypertension in elderly is still a big health problem. Nigella sativa seed extract, derived from a small plant originating in Middle east which can be found abundantly in Asia, has shown small antihypertensive effect in adult. Diuretic effect of Nigella sativa is thought to be the main mechanism for the effect but as it also shows anti-inflammatory and vasodilatory activity which are important contributors in arterial stiffness, the main pathogenesis of hypertension in elderly, thus it has a superior potential benefit for this population. We will conduct a randomized, double blind, placebo-controlled trial to prove the effect of Nigella sativa seed extract in elderly patients with hypertension. Our hypothesis is 300 mg Nigella sativa seed extract twice daily will have anti-hypertensive effect in the blood pressure of elderly with hypertension.
Detailed Description
The study will be conducted in Geriatric Outpatient Clinic of Cipto Mangunkusumo National Hospital, Jakarta, Indonesia. Eligibility criteria are men and women over 60 years old and available to participate in the study for 4 weeks with blood pressure higher than 140/90. Exclusion criteria are renal disease, hepatic failure, dementia and orthostatic hypotension and malignant hypertension. Outcome measures are systolic and diastolic blood pressure after 4 weeks administration of 300 mg Nigella sativa seed extract twice daily.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension
Keywords
Nigella sativa seed extract, hypertension, elderly

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Single Group Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
76 (Anticipated)

8. Arms, Groups, and Interventions

Intervention Type
Drug
Intervention Name(s)
Nigella sativa
Intervention Description
Drug name: Nigella sativa seed extract in capsule Dosage 300 mg Frequency: twice daily Duration: 4 weeks
Primary Outcome Measure Information:
Title
systolic blood pressure
Description
We aim to measure the difference in systolic blood pressure after 4 weeks administration of 300 mg Nigella sativa seed extract in elderly with hypertension
Time Frame
4 weeks
Secondary Outcome Measure Information:
Title
diastolic blood pressure
Description
We measure the difference of diastolic blood pressure after 4 weeks administration of 300 mg Nigella sativa seed extract in elderly with hypertension
Time Frame
4 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Men and women more than 60 years old Systolic Blood Pressure 140 mm Hg AND OR diastolic blood pressure 90 mmHg Available during study duration (4 weeks) Exclusion Criteria: Renal failure Hepatic failure Dementia Orthostatic hypotension Malignant hypertension
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Aulia Rizka, MD
Phone
+628125265600
Email
dr.auliarizka@yahoo.co.id
First Name & Middle Initial & Last Name or Official Title & Degree
Siti Setiati, PhD, MD
Phone
+6281389835588
Email
s_setiati@yahoo.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Aulia Rizka, MD
Organizational Affiliation
Faculty of Medicine University of Indonesia
Official's Role
Principal Investigator
Facility Information:
Facility Name
Cipto Mangunkusumo National Hospital
City
Jakarta
Country
Indonesia
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Aulia Rizka, MD
Phone
+628125265600
Email
dr.auliarizka@yahoo.co.id

12. IPD Sharing Statement

Learn more about this trial

Effect of Nigella Sativa Seed Extract on the Blood Pressure of Elderly With Hypertension

We'll reach out to this number within 24 hrs